Showing results (231-240 of 317) with videos related to

Sort By:
Pageof 32
EJNMMI Physics|October 27, 2015
Metal artifact reduction in patients with dental implants using multispectral three-dimensional data acquisition for hybrid PET/MRIJeanne M Gunzinger, Gaspar Delso, Andreas Boss, et al.
Plos One|June 4, 2020
The impact of atlas-based MR attenuation correction on the diagnosis of FDG-PET/MR for Alzheimer's diseases- A simulation study combining multi-center data and ADNI-dataTetsuro Sekine, Alfred Buck, Gaspar Delso, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 7, 2008
Chemotherapy response assessment in stage IV melanoma patients-comparison of 18F-FDG-PET/CT, CT, brain MRI, and tumormarker S-100BKlaus Strobel, Reinhard Dummer, Hans C Steinert, et al.
European Heart Journal|December 20, 2007
Feasibility of low-dose coronary CT angiography: first experience with prospective ECG-gatingLars Husmann, Ines Valenta, Oliver Gaemperli, et al.
Cancers|February 13, 2025
<sup>68</sup>Ga-DOTATATE PET/CT in the Initial Staging of Well-Differentiated Gastroenteropancreatic and Non-Gastroenteropancreatic Neuroendocrine Tumors: Results of a Prospective RegistryUr Metser, Roshini Kulanthaivelu, Julia Duder, et al.
Academic Radiology|August 13, 2024
Value of Dynamic Contrast-Enhanced MRI for Grade Group Prediction in Prostate Cancer: A Radiomics Pilot StudySeyed Ali Mirshahvalad, Adriano B Dias, Sangeet Ghai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2010
Risk-adapted FDG-PET/CT-based follow-up in patients with diffuse large B-cell lymphoma after first-line therapyU Petrausch, P Samaras, S R Haile, et al.
Frontiers in Oncology|November 10, 2022
Prognostic value of PET/CT and MR-based baseline radiomics among patients with non-metastatic nasopharyngeal carcinomaRoshini Kulanthaivelu, Andres Kohan, Ricarda Hinzpeter, et al.
Physics in Medicine and Biology|November 29, 2016
Stability of radiomic features in CT perfusion mapsM Bogowicz, O Riesterer, R A Bundschuh, et al.
Clinical Nuclear Medicine|September 8, 2023
Impact of 18F-DCFPyL PET/MRI in Selecting Men With Low-/Intermediate-Risk Prostate Cancer for Focal Ablative TherapiesAdriano Basso Dias, Sangeet Ghai, Claudia Ortega, et al.
Pageof 32